RPRX•benzinga•
Royalty Pharma Raises Full Year 2024 Guidance For Portfolio Receipts From $2.70B - $2.775B To $2.75B - $2.80B
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 6, 2024 by benzinga